National Press Club

Defining and Measuring Quality in Cancer Care

Defining and Measuring Quality in Cancer Care

September 12, 2019 9:30 AM

Location: Ballroom

The National Comprehensive Cancer Network® (NCCN®) hosts a policy summit on challenges and promising practices for measuring quality cancer care delivery with a look toward the future. Join the conversation online with the hashtag #NCCNPolicy.

What NCCN Policy Summit: Defining, Measuring, and Applying Quality in an Evolving Health Policy Landscape and the Implications for Cancer Care

The summit will explore the application and measurement of quality in cancer care delivery systems, and the future of defining, standardizing, and reporting quality in cancer care.

When Thursday, September 12th | 9:30 AM – 3:00 PM (Breakfast at 8:30 AM)

Where The National Press Club – 13th Floor
529 14th Street NW
Washington, D.C.



Wui-Jin Koh, MD
Chief Medical Officer, NCCN
Panel Moderation:

Clifford Goodman, PhD
Senior Vice President, The Lewin Group

Address on defining and measuring quality under current value-based care models:

Kerin Adelson, MD
Chief Quality Officer and Deputy Chief Medical Officer, Smilow Cancer Hospital

Diana Verrilli, MPH
VP/GM of Managed Care, Quality & Provider Solutions, McKesson Specialty Health

Address on the role of standardized performance measures in ensuring quality in cancer care:

Shantanu Agrawal, MD, MPhil
CEO, National Quality Forum (NQF)

Additional Panelists include:

Alan Balch, PhD
National Patient Advocate Foundation

Alexandra Chong, PhD
OCM Team Lead
Centers for Medicare & Medicaid Services (CMS)

Reena Duseja, MD, MS
Chief Medical Officer for Quality Measurement
Centers for Medicare & Medicaid Services (CMS)

Nancy Keating, MD, MPH
Professor of Health Care Policy & Medicine
Harvard Medical School

Bryan Loy, MD, MBA
Physician Lead – Oncology, Laboratory, and Personalized Medicine

Jim Martineau, MBA
Director, Product Management & Operations

Kashyap Patel, MD
Oncologist, Managing Partner
Carolina Blood and Cancer Care

Gaurav Singal, MD
Chief Data Officer
Foundation Medicine

Lawrence N. Shulman, MD
Deputy Director for Clinical Services
Abramson Cancer Center at the University of Pennsylvania

Jacqueline Waldrop, MS
Director, Oncology Grant Officer
Pfizer, Inc.

Ronald S. Walters, MD, MBA, MHA, MS
Associate Head for the Institute for Cancer Care Innovation
The University of Texas
MD Anderson Cancer Center
NCCN Board of Directors

Tracy Wong, MBA
Director, Quality and Value
Seattle Cancer Care Alliance

For more information and the full agenda, visit Take part in the online discussion with the hashtag #NCCNPolicy.

To request a complimentary press pass, contact Rachel Darwin at or 267-622-6624.

# # #

About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of 28 leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, efficient, and accessible cancer care so patients can live better lives. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. By defining and advancing high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers around the world.

Clinicians, visit Patients and caregivers, visit Media, visit Follow NCCN on Twitter @NCCN, Facebook @NCCNorg, and Instagram @NCCNorg.

For More Information On This Event, Contact:

Rachel Darwin